Plain-English translation of NCT05532878 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This trial is studying a blood thinner called to see how your body processes it and whether it is safe for people like you who use peritoneal dialysis and have atrial fibrillation (an irregular heartbeat). Atrial fibrillation increases your risk of stroke, and blood thinners can help prevent that. Researchers want to understand how this medication works specifically in people on peritoneal dialysis, since most previous studies only looked at people on a different type of dialysis.
People on peritoneal dialysis with heart rhythm problems face a higher stroke risk, but doctors aren't sure which blood thinners are safest and most effective for them. This medication has been studied in other dialysis patients, but never in peritoneal dialysis patients—and the way your body processes medications may be different. This study aims to fill that gap so doctors can confidently recommend the best treatment for you.
As a participant, you would take the study medication while researchers monitor how your body handles it through blood tests and safety assessments. The trial involves 50 participants total, and you would be followed to ensure the medication is working well for you and not causing problems. Details about visit frequency and study duration are not specified in this record, so you would learn more if you contacted the study team.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Hong Kong